U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.

Cover of StatPearls

StatPearls [Internet].

Show details

Conjoined Twins

; .

Author Information and Affiliations

Last Update: August 8, 2023.

Continuing Education Activity

Conjoined twins refers to twins that are physically fused in utero and consequently at birth. This type of pregnancy is a complicated phenomenon that requires an interprofessional team approach to manage it effectively. This activity outlines the evaluation and management of conjoined twins and highlights the role of the healthcare team in improving care for patients with this condition.

Objectives:

  • Explain the etiology of conjoined twins.
  • Identify the epidemiology of conjoined twins.
  • Outline the management considerations for conjoined twins.
  • Review the importance of collaboration and communication amongst the interprofessional team to enhance care coordination for conjoined twins.
Access free multiple choice questions on this topic.

Introduction

Conjoined twins refers to twins that are physically fused in utero and consequently at birth. The first mention of conjoined twins historically comes from the neolithic period.[1] The condition is proposed to result from either fission or fusion.[2] It happens when a monozygotic twin pregnancy cleaves more than 13 days after fertilization. Conjoined twins are monochorionic (one placenta) and monoamniotic (one amniotic sac). Conjoined twins exist in a female to male ratio of 3 to 1. This type of pregnancy is a complicated phenomenon that requires an interprofessional approach to manage it effectively.[2]

Etiology

The most commonly believed etiology of conjoined twinning is either partial fission or secondary fusion. Both of these processes can be used to explain the embryological and anatomical findings observed in conjoined twins. However, the fission and fusion theories do not unequivocally account for every possible conjunction and cannot be applied to the full spectrum of findings in conjoined twins. Conjoined twins can be broadly categorized into non-dorsally conjoined twins (which includes ventral, lateral, and caudal conjunction) and dorsally conjoined twins.

Non-dorsal conjunction may have a varied presentation but typically demonstrates a single shared umbilical cord along with the sharing of organs. The dorsal conjunction presents with two umbilical cords and mostly separate internal organs. It is proposed that non-dorsal conjunction may be initiated by duplication of the axial primordia, which leads to a change in the axial orientation and/or interaction aplasia. Dorsal conjunction may occur because of secondary fusion of initially separate monozygotic twins.[3]

Epidemiology

The incidence of conjoined twins is one per 50,000 to 200,000 births.[4] The rate of stillbirth is high and is estimated to be around 60 percent.[2] There is no increased risk in future pregnancies. Accurate epidemiology across multiple countries and ethnicities cannot be calculated because the condition is underreported. Conjoined twins are associated with a higher predominance of the female sex.[5] The female to male ratio is 3 to 1.[2]

Pathophysiology

Conjoined twinning is the result of cleavage or axis duplication that occurs after day 13 of fertilization. They are described according to the site of fusion.[6]

The following are the types of conjoined twins along with their frequency: 

  • Thoraco-omphalopagus (joined at thorax and abdomen) 28%
  • Thoracopagus (joined at the thorax) 18.5%
  • Omphalopagus (joined at the abdomen) 10%
  • Heteropagus (parasitic twins) 10%  
  • Craniopagus (joined at the level of the cranium) 6%

Less commonly observed conjoined twins include:[7]

  • Pyopagus (joined at sacrum and perineum)
  • Rachipagus (joined at vertebral column)
  • Ischiopagus (joined at lower abdomen and pelvis)
  • Cephalopagus (joined from head to umbilicus)

The site of fusion and organs involved are a primary consideration for separation surgery. Typically, 25% of live births live long enough to be candidates for surgery.[6]

History and Physical

A conjoined twin pregnancy presents the same way as other twin pregnancies, with a uterine size greater than expected for gestational age. Due to advances in imaging techniques, most cases these days are recognized early on prenatal ultrasonographic imaging.[8]

Evaluation

First-trimester ultrasonography remains the best modality of diagnosis early in the pregnancy. Prenatal magnetic resonance imaging can also help with identifying the type of conjunction, embryological malformations, and tissue characterization. Prenatal imaging should be used to inform the postnatal magnetic resonance imaging.[9] Modern methods like 3D printing may aid with surgical pre-planning and subsequent separation if applicable.[10]

Treatment / Management

The conjoined twins that survive until birth can be broadly categorized into two categories, those who can be surgically separated and those who cannot. The determination of which set of conjoined twins can be separated is an interprofessional effort employing imaging modalities and multiple reviews. The conjoined twins that extensively share vital organs can generally not be separated as separation might lead to the death of one or both twins. This presents some ethical dilemmas in the surgical management of conjoined twins, but the overall decision still lies with the parents. Some cases might need the involvement of the hospital ethics committee.[11] 

Surgical management requires identification of the anatomic relationship of the conjunction between the twins. Three-dimensional modeling and simulations help the team in making surgical decisions. The use of tissue expansion preoperatively is very helpful due to issues with the closure of the abdominal wall. At least 1 simulation of the separation event is recommended preoperatively as that helps with the outcome of conjoined twins.[12]

During medical management, some pharmacokinetic considerations must be kept in mind as the shared circulation of the conjoined twins may have a variable volume of distribution and clearance.[13]

Differential Diagnosis

Conjoined twins are a rare condition that is uniquely identifiable on prenatal ultrasonography. However, the differential diagnosis might include conditions with aberrant ultrasonographic findings such as cystic hygroma, teratoma, and lymphangioma.

Prognosis

Conjoined twins generally have a poor prognosis. The total survival rate is 7.5%. Only 60% of the surgically separated cases survive.[14] Antenatal imaging, postnatal surgery if applicable, use of tissue expansion in surgery, and cadaveric transplant for vital organs that are shared between the twins, might lead to a better prognosis.

Complications

The intrauterine demise of the twins is likely given the complicated nature of the pregnancy. Postnatally, complications related to the complex anatomy of the twins may lead to death. If surgery is an option, complications related to separation include organ failure, skin defects, surgical infection, bleeding, injury to internal organs and/or vasculature, and failure to complete the procedure.

Deterrence and Patient Education

Conjoined twins present a complex psychosocial challenge. Surgical separation is associated with ethical dilemmas, especially in cases of an unequal separation. Furthermore, the conjoined twins have difficulty in establishing individuality and can have a twinning reaction.[15] The involvement of social workers is important for the management of conjoined twins. Patient education regarding the challenges of conjoined twins and the poor prognosis can help the family in taking care of the conjoined twins.[16]

Enhancing Healthcare Team Outcomes

The approach to the management of conjoined twins is complicated. Conjoined twins can be separated into the following groups with regards to prognosis:

  • Those who do not survive in-utero
  • Those who survive pregnancy but do not survive past infancy 
  • Those who survive infancy, but cannot be separated
  • Those who survive infancy and can be surgically separated

This type of classification may be preferred over anatomic classification because it directs the management specifically. It is also helpful because surgical separation, if applicable, should be performed in infancy. [Level V][17]

There is also an ethical dilemma associated with the management of conjoined twins. Ethical considerations should be kept in mind as they relate to prognosis. The following clinical /ethical scenarios can be observed: 

  • Survival time is 6 months or less
  • Both twins survive after separation
  • Both twins survive without separation
  • One twin dies after separation
  • Both twins die the following separation
  • Both twins die without separation

Keeping these considerations in mind, the interprofessional medical team can make decisions regarding surgical treatment and palliative care.[18] Some consider sacrificial separation (performed when it is known preoperatively that surgery will be lethal for one of the twins) unethical.[11] The sharing of organs, in particular, the heart is an important consideration because it determines whether surgical treatment is possible and its prognostic outlook.[2] Prenatal counseling of the family plays an important role because of the complicated nature of management and prognosis.[19]

Obstetric consideration:

Timing and mode of delivery should be individualized, taking into consideration any antenatal complications and the altered anatomy based on prenatal imaging. Cesarean delivery is often required, as vaginal delivery may not be possible depending on where the twins are joined. An interprofessional team is important to address the challenges of a complicated pregnancy and birth process. [19] The pregnancy should be managed in conjunction with a maternal-fetal medicine  (MFM) specialist and should be delivered at a tertiary care center equipped to manage the twins postnatally. Pregnancy termination is an option and should be offered in accordance with state laws.

Medical consideration: 

Nutrition support is very important in the management of conjoined twins during the neonatal period.[20] Medications should be administrated with caution and increased monitoring because of the variation of pharmacokinetic variables.[13]

Surgical consideration:

Identification of the anatomical structures is accomplished with postnatal imaging, preferably MRI, keeping prenatal imaging in mind.[9] Three-dimensional modeling and simulation-based clinical rehearsal are important in preoperative preparation.[12][21] The surgical survival rate is around 66.7%. [Level V][22]

Conjoined twins should be cared for at specialized centers with MFM, neonatal intensive care unit (NICU) and pediatric subspecialty availability. [23][Level V] Nursing care (maternal) considerations include privacy, grief counseling, if necessary, and providing emotional support to the patient and family. 

The management of conjoined twins requires the intimate cooperation of an interprofessional team.[24]

Review Questions

References

1.
Kobylarz K. History of treatment of conjoined twins. Anaesthesiol Intensive Ther. 2014 Apr-Jun;46(2):116-23. [PubMed: 24858972]
2.
Mian A, Gabra NI, Sharma T, Topale N, Gielecki J, Tubbs RS, Loukas M. Conjoined twins: From conception to separation, a review. Clin Anat. 2017 Apr;30(3):385-396. [PubMed: 28195364]
3.
Boer LL, Schepens-Franke AN, Oostra RJ. Two is a Crowd: Two is a Crowd: On the Enigmatic Etiopathogenesis of Conjoined Twinning. Clin Anat. 2019 Jul;32(5):722-741. [PMC free article: PMC6849862] [PubMed: 31001856]
4.
De Ugarte DA, Boechat MI, Shaw WW, Laks H, Williams H, Atkinson JB. Parasitic omphalopagus complicated by omphalocele and congenital heart disease. J Pediatr Surg. 2002 Sep;37(9):1357-8. [PubMed: 12194133]
5.
Mutchinick OM, Luna-Muñoz L, Amar E, Bakker MK, Clementi M, Cocchi G, da Graça Dutra M, Feldkamp ML, Landau D, Leoncini E, Li Z, Lowry B, Marengo LK, Martínez-Frías ML, Mastroiacovo P, Métneki J, Morgan M, Pierini A, Rissman A, Ritvanen A, Scarano G, Siffel C, Szabova E, Arteaga-Vázquez J. Conjoined twins: a worldwide collaborative epidemiological study of the International Clearinghouse for Birth Defects Surveillance and Research. Am J Med Genet C Semin Med Genet. 2011 Nov 15;157C(4):274-87. [PMC free article: PMC4457318] [PubMed: 22002822]
6.
Kaufman MH. The embryology of conjoined twins. Childs Nerv Syst. 2004 Aug;20(8-9):508-25. [PubMed: 15278382]
7.
Baken L, Rousian M, Kompanje EJ, Koning AH, van der Spek PJ, Steegers EA, Exalto N. Diagnostic techniques and criteria for first-trimester conjoined twin documentation: a review of the literature illustrated by three recent cases. Obstet Gynecol Surv. 2013 Nov;68(11):743-52. [PubMed: 24193193]
8.
Melo Â, Dinis R, Portugal A, Sousa AI, Cerveira I. Early prenatal diagnosis of parapagus conjoined twins. Clin Pract. 2018 Mar 28;8(2):1039. [PMC free article: PMC5890089] [PubMed: 29657701]
9.
Mehollin-Ray AR. Prenatal and postnatal radiologic evaluation of conjoined twins. Semin Perinatol. 2018 Oct;42(6):369-380. [PubMed: 30170825]
10.
Mathew RP, Francis S, Basti RS, Suresh HB, Rajarathnam A, Cunha PD, Rao SV. Conjoined twins - role of imaging and recent advances. J Ultrason. 2017 Dec;17(71):259-266. [PMC free article: PMC5769666] [PubMed: 29375901]
11.
Kallberg L. The ethics of separating conjoined twins: two arguments against. Theor Med Bioeth. 2018 Feb;39(1):27-56. [PubMed: 29446009]
12.
Fallon SC, Olutoye OO. The surgical principles of conjoined twin separation. Semin Perinatol. 2018 Oct;42(6):386-392. [PubMed: 30477661]
13.
Rodman E, Placencia JL. Pharmaceutical considerations with conjoined twins. Semin Perinatol. 2018 Oct;42(6):350-354. [PubMed: 30122608]
14.
Brizot Mde L, Liao AW, Lopes LM, Silva MM, Krebs V, Schultz R, Zugaib M. [Conjoined twins: prenatal diagnosis, delivery and postnatal outcome]. Rev Bras Ginecol Obstet. 2011 May;33(5):211-8. [PubMed: 21860927]
15.
Lipsky K. Conjoined twins: psychosocial aspects. AORN J. 1982 Jan;35(1):58-61. [PubMed: 6915747]
16.
Carreker C, De Jong H, Javor V, Fox L, Jacome J, Johns C, Springmeyer K, Davies J. Family support and media considerations with conjoined twins. Semin Perinatol. 2018 Oct;42(6):393-401. [PubMed: 30201416]
17.
Harper RG, Kenigsberg K, Sia CG, Horn D, Stern D, Bongiovi V. Xiphopagus conjoined twins: a 300-year review of the obstetric, morphopathologic, neonatal, and surgical parameters. Am J Obstet Gynecol. 1980 Jul 01;137(5):617-29. [PubMed: 6992583]
18.
Thomas A, Johnson K, Placencia FX. An ethically-justifiable, practical approach to decision-making surrounding conjoined-twin separation. Semin Perinatol. 2018 Oct;42(6):381-385. [PMC free article: PMC6786881] [PubMed: 30217664]
19.
C Sager E, Thomas A, C Sundgren N. Conjoined twins: Pre-birth management, changes to NRP, and transport. Semin Perinatol. 2018 Oct;42(6):321-328. [PubMed: 30150080]
20.
Bergner EM, Gollins L, Massieu LA, Hurst N, Hair AB. Nutritional considerations in the care of conjoined twins. Semin Perinatol. 2018 Oct;42(6):355-360. [PubMed: 30197028]
21.
Parmekar S, McMullen L, Washington C, Arnold JL. Role of simulation in preparation for the care of conjoined twins-prenatal preparation to separation. Semin Perinatol. 2018 Oct;42(6):329-339. [PubMed: 30144953]
22.
Tannuri AC, Batatinha JA, Velhote MC, Tannuri U. Conjoined twins: twenty years' experience at a reference center in Brazil. Clinics (Sao Paulo). 2013;68(3):371-7. [PMC free article: PMC3611880] [PubMed: 23644858]
23.
Willobee BA, Mulder M, Perez EA, Hogan AR, Brady AC, Sola JE, Thorson CM. Predictors of in-hospital mortality in newborn conjoined twins. Surgery. 2019 Nov;166(5):854-860. [PMC free article: PMC10353765] [PubMed: 31402130]
24.
Luton A, Estrada N, Barrientez K, McGinnis J, Pitlik J, Carter A, Davenport L, Davies J. Nursing considerations and interdisciplinary coordination in the care of conjoined twins. Semin Perinatol. 2018 Oct;42(6):340-349. [PubMed: 30185382]

Disclosure: Ahmed Rafay Afzal declares no relevant financial relationships with ineligible companies.

Disclosure: Freddy Montero declares no relevant financial relationships with ineligible companies.

Copyright © 2024, StatPearls Publishing LLC.

This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.

Bookshelf ID: NBK560839PMID: 32809674

Views

  • PubReader
  • Print View
  • Cite this Page

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...